EMCN and neoplasm: The number of endomucin-expressing endothelial cells in tumor tissue was decreased in the GANT61-treated group (Figure 2E,F), and the number of endomucin-expressing endothelial cells in tumor tissue per unit area was significantly decreased in the GANT61-treated group compared to the control group (Figure 2H, p < 0.05).